Although further exploration is required to clarify the underlying molecular mechanism how TTK regulates DPYSL3 expression and then potentiates malignant behavior, our study offers a valuable insight for the specific management patients with lung cancer. The gene discussed is DPYSL3; the disease is lung carcinoma.